ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
ORIC Pharmaceuticals at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
ORIC Pharmaceuticals takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8103. Its session covers how the PRC2-blocking drug rinzimetostat affects cell identity and androgen-receptor signaling in prostate cancer, including preclinical models and patient samples.
| Organization | ESMO 2026 Attendance |
|---|---|
Clinical-stage oncology company developing treatments against cancer resistance mechanisms, with programs in prostate and lung cancer. | Booth Exhibiting at Booth 8103 |
Find decision makers at ORIC Pharmaceuticals
Tell us what you sell and we’ll find the people at ORIC Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction